Related references
Note: Only part of the references are listed.Neurological outcome of long-term glioblastoma survivors
Andreas F. Hottinger et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Optic Nerve Dysfunction in a Mouse Model of Neurofibromatosis-1 Optic Glioma
Balazs Hegedus et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma
Balazs Hegedus et al.
CANCER RESEARCH (2008)
Health supervision for children with neurofibromatosis
Gerald B. Schaefer et al.
PEDIATRICS (2008)
Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas
C. F. Parsa et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program
Paola Dalla Via et al.
NEURO-ONCOLOGY (2007)
Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials
Benjamin C. M. Chang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations
Robert Listernick et al.
ANNALS OF NEUROLOGY (2007)
Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
Darcy H. Wolsey et al.
JOURNAL OF AAPOS (2006)
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
DN Franz et al.
ANNALS OF NEUROLOGY (2006)
Neurofibromatosis type 1 and optic pathway gliomas - Follow-up of 54 patients
S Thiagalingam et al.
OPHTHALMOLOGY (2004)
Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1
MA Blazo et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy
E Lacaze et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
